ABBV-722
Sponsors
AbbVie
Conditions
Healthy VolunteerHealthy Volunteers
Phase 1
A Study to Assess How the Drug Moves Through the Body, Adverse Events, and Tolerability of Oral ABBV-722 Capsules of Single and Multiple Ascending Doses in Adult Participants and Single Doses in Adult Asian Participants
CompletedNCT06673238
Start: 2024-10-29End: 2026-06-25Updated: 2026-07-27
A Phase 1 Study of a Tablet Form of ABBV-722 Taken With and Without Food in Healthy Adult Participants
CompletedNCT07361367
Start: 2026-01-15End: 2026-03-23Updated: 2026-04-24
A Phase 1 Study of the Safety and How the Body Processes ABBV-722 and Upadacitinib After Multiple Oral Doses in Healthy Adult Participants
CompletedNCT07425899
Start: 2026-02-26End: 2026-06-05Updated: 2026-08-04
A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants
CompletedNCT07502417
Start: 2026-03-27End: 2026-07-02Updated: 2026-07-30
A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.
CompletedNCT07567781
Start: 2026-04-30End: 2026-07-21Updated: 2026-08-20
A Phase 1 Study to Assess the Effect of Itraconazole on ABBV-722 in Healthy Adult Participants
Active, not recruitingNCT07599761
Start: 2026-05-07End: 2026-09-01Updated: 2026-08-28